Arylsulfonamide CCR3 antagonists

Details for Australian Patent Application No. 2010239341 (hide)

Owner Axikin Pharmaceuticals, Inc.

Inventors Ly, Tai Wei; Forrester, Jared Andrew

Agent HENRY HUGHES LIMITED

Pub. Number AU-A-2010239341

PCT Pub. Number WO2010/123960

Priority 61/171,780 22.04.09 US

Filing date 21 April 2010

Wipo publication date 28 October 2010

International Classifications

C07D 295/26 (2006.01) Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

A61K 31/551 (2006.01) - having two nitrogens as ring hetero atoms, e.g. clozapine, dilazep

A61P 11/06 (2006.01) Drugs for disorders of the respiratory system

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

Event Publications

10 November 2011 PCT application entered the National Phase

  PCT publication WO2010/123960 Priority application(s): WO2010/123960

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010239346-Overmolded diaphragm pump

2010239340-2,5-disubstituted arylsulfonamide CCR3 antagonists